Targeted therapies for renal cell carcinoma: more gains from using them again

Por Gan, H.K., Seruga, B., Knox, J.J.
Publicado em 2009

Managing toxicities and optimal dosing of targeted drugs in advanced kidney cancer

Por Seruga, B., Gan, H.K., Knox, J.J.
Publicado em 2009

Medical oncology workload in Canada: infrastructure, supports, and delivery of clinical care

Por Fundytus, A., Hopman, W.M., Hammad, N., Biagi, J.J., Sullivan, R., Vanderpuye, V., Seruga, B., Lopes, G., Sengar, M., Brundage, M.D., Booth, C.M.
Publicado no Curr Oncol (2018)